Dermatology and Skin Surgery Center – FDA Inspection, Mar 16, 2017

Record Details

This FDA Inspection record concerns Dermatology and Skin Surgery Center, with an inspection on March 16, 2017, issued by the Philadelphia District Office, covering human drugs.

Company: Dermatology and Skin Surgery Center
Inspection Date: March 16, 2017
Product Type: Human Drugs
Office: Philadelphia District Office
Person: Stephanie C. Mangigian (Company Rep)

View Company Profile

ID · a89e3d07-7eb0-46b6-b7c2-f1ea824eac2f

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number: 1014540
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dermatology and Skin Surgery Center

FDA Inspection

Dermatology and Skin Surgery CenterMarch 16, 2017